BYSI — BeyondSpring Inc

Founder-Led

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About BeyondSpring Inc

BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on developing and selling clinical-stage biopharmaceutical therapies focused on oncology and immunology. The company operates through two segments: the Plinabulin pipeline and the TPD platform. The company's lead asset is Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$1.36
Market Cap$64.6M
Float31.7M
Shares Outstanding41.1M
P/E (Forward)10.54
Price/Sales (TTM)45.99
vs. Analyst Target-8.1% to analyst PT
Revenue (TTM)$1.9M
Dividend RateNone
Analyst Target Price$1.25 (1 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $180,000 -$61.0M $180,000 -$63.7M
2021 $1.4M -$64.2M $1.4M -$64.5M
2022 $1.4M -$33.3M $1.4M -$35.0M
2023 $1.8M -$21.0M -$302,000 -$13.6M
2024 N/A -$11.1M -$285,000 -$8.5M
2025 N/A -$8.0M -$87,000 -$8.9M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 N/A -$1.8M
Sep 2025 N/A -$1.5M
Dec 2025 N/A -$9.1M
Mar 2026 N/A -$2.2M

Ownership & Float

Insider Ownership14.9%
Institutional Ownership14.6%
Short Float6.9%
% of All Funds Holding0.28%
Number of Funds Holding22

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$1.61Near-term / short-term trend
Weekly40-Week SMA$1.74Medium-term trend
Weekly80-Week SMA$1.77Cyclical trend (business cycle)
Weekly200-Week SMA$1.64Secular trend (multi-year)
Monthly10-Month SMA$1.67Near-term monthly trend
Monthly20-Month SMA$1.76Medium-term monthly trend
Monthly40-Month SMA$1.65Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$2.10 resistance 6.56x 4 months ago

Historical Earnings Reactions (32 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.37% 0.00% 43.75% 6.67% -3.70%
1 Day -1.20% 0.00% 46.88% 10.60% -20.59%
1 Week -3.88% -2.99% 40.63% 15.84% -34.52%
2 Weeks -4.46% -3.45% 25.81% 37.62% -37.45%
1 Month -1.28% -3.78% 38.71% 55.44% -47.74%

Next earnings: May 11, 2026

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan1.6%44.4%9
Feb-5.7%44.4%9
Mar11.7%33.3%9
Apr-2.6%40.0%10
May8.7%66.7%9
Jun11.4%66.7%9
Jul-13.3%0.0%9
Aug22.6%44.4%9
Sep-6.3%55.6%9
Oct-6.7%33.3%9
Nov-5.2%33.3%9
Dec14.0%44.4%9

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.14% 44.6% 433
Tuesday 0.18% 46.4% 474
Wednesday 0.13% 47.1% 471
Thursday -0.22% 41.9% 463
Friday 0.55% 51.5% 464

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 14.6%

Insider Transactions — Smart Summary

Total insider ownership: 14.9%

Founder-led management: Lan Huang (Co-founder, Chairman & Chief Executive Officer)

12-Month Insider Activity Summary

Total Filings17
Net Value+N/A
Net Shares Change-854,615
% of Float-2.7%
C-Suite Filings0
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
Decheng Capital China Life Sciences USD Fund III, L.P. -$1.8M 10 10 sell

Significant Filings

DateInsiderTitleNet ValuePrice After
2025-08-11 Decheng Capital China Life Sciences USD Fund III, L.P. -$1.2M Transaction at $3.05, now -55.4%
2025-10-20 Decheng Capital China Life Sciences USD Fund III, L.P. -$227,680.143 Transaction at $1.73, now -21.6%
2025-10-15 Decheng Capital China Life Sciences USD Fund III, L.P. -$259,164.578 Transaction at $1.68, now -19.3%
2025-10-10 Decheng Capital China Life Sciences USD Fund III, L.P. -$24,720.094 Transaction at $1.78, now -23.7%
2025-10-07 Decheng Capital China Life Sciences USD Fund III, L.P. -$35,964.08 Transaction at $1.78, now -23.6%
2025-10-02 Decheng Capital China Life Sciences USD Fund III, L.P. -$13,799.3 Transaction at $1.80, now -24.5%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for BeyondSpring Inc (BYSI) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for BYSI on Trend Edge →